119 related articles for article (PubMed ID: 8182373)
21. Growth hormone (GH) binding protein and GH interactions in vivo in the guinea pig.
Fairhall KM; Carmignac DF; Robinson IC
Endocrinology; 1992 Oct; 131(4):1963-9. PubMed ID: 1396340
[TBL] [Abstract][Full Text] [Related]
22. Human growth hormone-variant is a biologically active somatogen and lactogen.
MacLeod JN; Worsley I; Ray J; Friesen HG; Liebhaber SA; Cooke NE
Endocrinology; 1991 Mar; 128(3):1298-302. PubMed ID: 1999151
[TBL] [Abstract][Full Text] [Related]
23. The sensitivity of hepatic CYP2C gene expression to baseline growth hormone (GH) bioactivity in dwarf rats: effects of GH-binding protein in vivo.
Wells T; Mode A; Floby E; Robinson IC
Endocrinology; 1994 May; 134(5):2135-41. PubMed ID: 8156914
[TBL] [Abstract][Full Text] [Related]
24. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.
Tanaka T; Shiu RP; Gout PW; Beer CT; Noble RL; Friesen HG
J Clin Endocrinol Metab; 1980 Nov; 51(5):1058-63. PubMed ID: 7419681
[TBL] [Abstract][Full Text] [Related]
25. Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.
Bustamante JJ; Grigorian AL; Muñoz J; Aguilar RM; Treviño LR; Martinez AO; Haro LS
Growth Horm IGF Res; 2010 Aug; 20(4):298-304. PubMed ID: 20472479
[TBL] [Abstract][Full Text] [Related]
26. Biological activities of human growth hormone and its derivatives estimated by measuring DNA synthesis in Nb2 node rat lymphoma cells.
Emoto N; Tsushima T; Shizume K; Tanaka T; Saji M; Ohba Y; Wakai K; Arai M; Ohmura E
Acta Endocrinol (Copenh); 1987 Feb; 114(2):283-91. PubMed ID: 3825444
[TBL] [Abstract][Full Text] [Related]
27. Chimeric bovine-human growth hormone prepared by recombinant DNA technology: binding properties and biological activity.
Binder L; Vogel T; Hadary D; Elberg G; Gertler A
Mol Endocrinol; 1989 Jun; 3(6):923-30. PubMed ID: 2739655
[TBL] [Abstract][Full Text] [Related]
28. A novel bioassay for human somatogenic activity in serum samples supports the clinical reliability of immunoassays.
Rowland JE; Marshall NJ; Leung KC; Ho KK; Cotterill AM; Rowlinson SW; Waters MJ
Clin Endocrinol (Oxf); 2002 Apr; 56(4):475-85. PubMed ID: 11966740
[TBL] [Abstract][Full Text] [Related]
29. Investigation into the release of bioactive recombinant human growth hormone from normal and low-viscosity poly(methylmethacrylate) bone cements.
Goodwin CJ; Braden M; Downes S; Marshall NJ
J Biomed Mater Res; 1997 Jan; 34(1):47-55. PubMed ID: 8978652
[TBL] [Abstract][Full Text] [Related]
30. A serum-free medium for culturing lactogen dependent and autonomous NB2 node lymphoma cells.
Walker A; Croze F; Friesen HG
Endocrinology; 1987 Jun; 120(6):2389-97. PubMed ID: 3552636
[TBL] [Abstract][Full Text] [Related]
31. Identification of two specific prolactin binding sites on Nb2 rat lymphoma cells.
Rillema JA; Lawson DM
Proc Soc Exp Biol Med; 1994 Jan; 205(1):75-9. PubMed ID: 8115353
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of human growth hormone-stimulated mitogenesis of Nb2 node lymphoma cells by 12-O-tetradecanoyl-phorbol-13-acetate.
Gertler A; Walker A; Friesen HG
Endocrinology; 1985 Apr; 116(4):1636-44. PubMed ID: 3971932
[TBL] [Abstract][Full Text] [Related]
33. A growth hormone/prolactin-binding protein in human milk.
Mercado M; Baumann G
J Clin Endocrinol Metab; 1994 Dec; 79(6):1637-41. PubMed ID: 7989468
[TBL] [Abstract][Full Text] [Related]
34. An investigation into the lability of the bioactivity of human growth hormone using the ESTA bioassay.
Dattani MT; Ealey PA; Pringle PJ; Hindmarsh PC; Brook CG; Marshall NJ
Horm Res; 1996; 46(2):64-73. PubMed ID: 8871184
[TBL] [Abstract][Full Text] [Related]
35. Receptors for lactogenic hormones in the ovine corpus luteum. I: A major discrepancy in the specific binding of radiolabelled ovine prolactin and human growth hormone.
Bramley TA; Menzies GS; McNeilly AS; Friesen HG
J Endocrinol; 1987 Jun; 113(3):365-74. PubMed ID: 3114405
[TBL] [Abstract][Full Text] [Related]
36. A novel specific bioassay for serum human growth hormone.
Ishikawa M; Nimura A; Horikawa R; Katsumata N; Arisaka O; Wada M; Honjo M; Tanaka T
J Clin Endocrinol Metab; 2000 Nov; 85(11):4274-9. PubMed ID: 11095467
[TBL] [Abstract][Full Text] [Related]
37. The use of intermediate electron acceptors to enhance MTT bioreduction in a microculture tetrazolium assay for human growth hormone.
Goodwin CJ; Holt SJ; Downes S; Marshall NJ
Life Sci; 1996; 59(20):1745-53. PubMed ID: 8890950
[TBL] [Abstract][Full Text] [Related]
38. The stoichiometry of growth hormone-binding protein complexes in human plasma: comparison with cell surface receptors.
Baumann G; Lowman HB; Mercado M; Wells JA
J Clin Endocrinol Metab; 1994 May; 78(5):1113-8. PubMed ID: 8175967
[TBL] [Abstract][Full Text] [Related]
39. Somatogenic and lactogenic activity of the recombinant 22 kDa isoform of human placental growth hormone.
Igout A; Frankenne F; L'Hermite-Balériaux M; Martin A; Hennen G
Growth Regul; 1995 Mar; 5(1):60-5. PubMed ID: 7749349
[TBL] [Abstract][Full Text] [Related]
40. Characterization of dimeric forms of human pituitary growth hormone by bioassay, radioreceptor assay, and radioimmunoassay.
Brostedt P; Luthman M; Wide L; Werner S; Roos P
Acta Endocrinol (Copenh); 1990 Feb; 122(2):241-8. PubMed ID: 2316312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
